Jupiter Endovascular Funding Means Green Light for Pulmonary Embolism Pivotal Trial

New funding will be used to support Jupiter Endovascular in its upcoming pivotal trial for Pulmonary Embolism. It will also … continue reading “Jupiter Endovascular Funding Means Green Light for Pulmonary Embolism Pivotal Trial”

VARIPULSE™ Pulse Field Ablation (PFA) Platform Gains CE Mark

Biosense Webster, Inc., has announced European CE mark approval of the VARIPULSE™ Platform. The approval covers the treatment of symptomatic drug refractory … continue reading “VARIPULSE™ Pulse Field Ablation (PFA) Platform Gains CE Mark”

First Patient Receives Fully Implanted Acclaim® Cochlear Implant in Envoy Medical Early Feasibility Study

Envoy Medical® Corporation tells us the first patient has been enrolled and implanted in the Acclaim® Cochlear Implant early feasibility … continue reading “First Patient Receives Fully Implanted Acclaim® Cochlear Implant in Envoy Medical Early Feasibility Study”

First-in-Human Trial will Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation

Swiss company Argá Medtech has begun enrollment in a First-in-Human Clinical Trial of its CSE Ablation System in the treatment … continue reading “First-in-Human Trial will Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation”

Most read

Latest

^